TP53 and cancer: In cancer cells with wild type p53, high GMCL1 mRNA expression and low 53BP1 protein levels correlated with significant increased resistance to Cabazitaxel and Paclitaxel when compared to cells with low GMCL1 mRNA and high 53BP1 protein levels (Figure 3E).